The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•25 June 2026•

1 min read

Prosus invests $460 million in French health tech Alan at $6.3B valuation

Key Facts

1Dutch investment company Prosus invested $460 million in French health tech company Alan, valuing it at $6.3 billion.

Dutch investment company Prosus invested $460 million in French health tech startup Alan, valuing the company at $6.3 billion, according to Reuters. The investment marks an expansion move for Prosus in Europe as it seeks to bolster its portfolio in the fast-growing health tech sector.

Prosus shares closed at $8.66 on June 24, 2026, per market data. The deal comes amid rising investor interest in health tech, driven by demand for digital healthcare solutions. Alan is a leading French startup in this space, offering health insurance and preventive care services.

Investors are monitoring Prosus's venture investment performance, particularly its focus on high-growth sectors. No near-term catalysts are on the calendar for Prosus shares, but the deal could boost confidence in the company's investment strategy.

Sources: